<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0185-3325</journal-id>
<journal-title><![CDATA[Salud mental]]></journal-title>
<abbrev-journal-title><![CDATA[Salud Ment]]></abbrev-journal-title>
<issn>0185-3325</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0185-33252017000300119</article-id>
<article-id pub-id-type="doi">10.17711/sm.0185-3325.2017.015</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[An integrative overview of the cannabinergic system and mental health]]></article-title>
<article-title xml:lang="es"><![CDATA[Una revisión exhaustiva del sistema cannabinérgico y la salud mental]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Prospéro García]]></surname>
<given-names><![CDATA[Oscar E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rueda Orozco]]></surname>
<given-names><![CDATA[Pavel E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amancio Belmont]]></surname>
<given-names><![CDATA[Octavio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ruiz Contreras]]></surname>
<given-names><![CDATA[Alejandra E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Méndez Díaz]]></surname>
<given-names><![CDATA[Mónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional Autónoma de México Facultad de Medicina Departamento de Fisiología, Laboratorio de Cannabinoides]]></institution>
<addr-line><![CDATA[Coyoacán Distrito Federal]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional Autónoma de México Instituto de Neurobiología Departamento de Neurofisiología del Desarrollo y Neurofisiología]]></institution>
<addr-line><![CDATA[Coyoacán Distrito Federal]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Nacional Autónoma de México Facultad de Psicología Laboratorio de Neurogenómica Cognitiva, Coordinación de Psicobiología y Neurociencias]]></institution>
<addr-line><![CDATA[Coyoacán Distrito Federal]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<volume>40</volume>
<numero>3</numero>
<fpage>119</fpage>
<lpage>128</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0185-33252017000300119&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0185-33252017000300119&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0185-33252017000300119&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Background The endocannabinoid system (eCBs) is one of the modulatory systems widely expressed in the brain. It consists of receptors expressed in the cytoplasmic (CB1 and CB2), the mitochondrial membrane (CB1), and the endogenous ligands known as endocannabinoids, such as anandamide, 2AG and oleamide. CB1 has been found in excitatory and inhibitory neurons in the pre- and post-synaptic membranes. It is expressed in several brain areas such as the hippocampus, dorsal, and ventral striatum, amygdala and prefrontal cortex. The eCBs has been involved in the regulation of learning and memory, mood, energy balance, sleep, and drug addiction.  Objective Integrate existing information about the eCBs and its role in brain function and mental health.  Method Review of the information of basic and clinical relevance obtained from indexed scientific journals (PubMed/Medline, Scopus).  Results Basic and clinical research on eCBs related to central nervous system function is described.  Discussion and conclusion At present, the study of eCBs is of importance. The development of drugs that affect this system may be clinically useful to control different debilitating diseases. This is an area of interest to the scientific community and health care providers.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Antecedentes El sistema de endocannabinoides (eCBs) es uno de los sistemas moduladores más ampliamente expresados en el cerebro. Se compone de receptores expresados en la membrana citoplasmática (CB1 y CB2) y en la membrana mitocondrial (CB1) y ligandos endógenos conocidos como endocannabinoides, como anandamida, 2AG y oleamida. El CB1 se ha encontrado en neuronas excitadoras e inhibidoras, en las membranas pre- y pos-sináptica, en varias áreas cerebrales como el hipocampo, el estriado dorsal y ventral, y en la amígdala y la corteza prefrontal. El eCBs se ha relacionado con la regulación del aprendizaje y la memoria, del estado afectivo, del equilibrio energético, del sueño y del proceso de la adicción a las drogas.  Objetivo Integrar la información existente sobre el eCBs y su función sobre los procesos cerebrales y la salud mental.  Método Revisión de la información de relevancia básica y clínica obtenida de revistas científicas indexadas (PubMed/Medline, Scopus).  Resultados Se describe de manera concisa información de interés básico y clínico de la investigación sobre el eCBs relacionada con la función del sistema nervioso central.  Discusión y conclusión En la actualidad, el estudio del eCBs es indispensable debido a su potencial terapéutico. El desarrollo de fármacos que afecten este sistema puede ser clínicamente útil para controlar diferentes enfermedades debilitantes. Ésta es un área de interés para la comunidad científica y los proveedores de salud.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Cannabinoid system]]></kwd>
<kwd lng="en"><![CDATA[endocannabinoids]]></kwd>
<kwd lng="en"><![CDATA[cannabinoid receptor 1]]></kwd>
<kwd lng="en"><![CDATA[cannabinoid receptor 2]]></kwd>
<kwd lng="en"><![CDATA[mental health]]></kwd>
<kwd lng="es"><![CDATA[Sistema de cannabinoides]]></kwd>
<kwd lng="es"><![CDATA[endocannabinoides]]></kwd>
<kwd lng="es"><![CDATA[receptor para cannabinoides 1]]></kwd>
<kwd lng="es"><![CDATA[receptor para cannabinoides 2]]></kwd>
<kwd lng="es"><![CDATA[salud mental]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Retrograde signaling in the regulation of synaptic transmission: Focus on endocannabinoid]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alger]]></surname>
<given-names><![CDATA[B. E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Progress in Neurobiology]]></source>
<year>2002</year>
<volume>68</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>247-86</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Blockade of cannabinoid CB1 receptors alters contextual learning and memory]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arenos]]></surname>
<given-names><![CDATA[J. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Musty]]></surname>
<given-names><![CDATA[R. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Bucci]]></surname>
<given-names><![CDATA[D. J.]]></given-names>
</name>
</person-group>
<source><![CDATA[European Journal of Pharmacology]]></source>
<year>2006</year>
<volume>539</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>177-83</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Activation of the Cannabinoid Receptor Type 1 Decreases Glutamatergic and GABAergic Synaptic Transmission in the Lateral Amygdala of the Mouse]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Azad]]></surname>
<given-names><![CDATA[S. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Eder]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Marcicano]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Lutz]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Zieglgänsberger]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Rammes]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Learning &amp; Memory]]></source>
<year>2003</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>116-28</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Feasibility of Central Cannabinoid CB1 Receptor Imaging with [124I]AM281 PET Demonstrated in a Schizophrenic Patient]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berding]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
<name>
<surname><![CDATA[Gielow]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Buchert]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Donnerstag]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Brandau]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Müller-Vahl]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychiatry Research-Neuroimaging]]></source>
<year>2006</year>
<volume>147</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>249-56</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Endocannabinoid signaling and its regulation by nutrients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bisogno]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Maccarrone]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[BioFactors]]></source>
<year>2014</year>
<volume>40</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>373-80</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The endocannabinoid signalling system: Biochemical aspects. Pharmacology]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bisogno]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Ligresti]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[di Marzo]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<source><![CDATA[Biochemistry and Behavior]]></source>
<year>2005</year>
<volume>81</volume>
<page-range>224-38</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burns]]></surname>
<given-names><![CDATA[H. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Van Laere]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Sanabria-Bohórquez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Hamill]]></surname>
<given-names><![CDATA[T. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Bormans]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Eng]]></surname>
<given-names><![CDATA[W. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Hargreaves]]></surname>
<given-names><![CDATA[R. J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Proceedings of the National Academy of Sciences of the United States of America]]></source>
<year>2007</year>
<volume>104</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>9800-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cadas]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[di Tomaso]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Piomelli]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Journal of Neuroscience]]></source>
<year>1997</year>
<volume>17</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1226-42</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Endocannabinoids facilitate the induction of LTP in the hippocampus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carlson]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Alger]]></surname>
<given-names><![CDATA[B. E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature Neuroscience]]></source>
<year>2002</year>
<volume>5</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>723-4</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ceccarini]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Kuepper]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Kemels]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[van Os]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Henquet]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[van Laere]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Addiction Biology]]></source>
<year>2015</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>357-67</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ventral tegmental microinjection of delta9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana&#8217;s psychoactive ingredient]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Marmur]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Pulles]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Paredes]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Gardner]]></surname>
<given-names><![CDATA[E. L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Brain Research]]></source>
<year>1993</year>
<volume>621</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>65-70</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Polygenic inheritance and micro/minisatellites]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Comings]]></surname>
<given-names><![CDATA[D. E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Molecular Psychiatry]]></source>
<year>1998</year>
<volume>3</volume>
<page-range>21-31</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Functional disassociation of the central and peripheral fatty acid amide signaling systems]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cravatt]]></surname>
<given-names><![CDATA[B. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Saghatelian]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hawkins]]></surname>
<given-names><![CDATA[E. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Clement]]></surname>
<given-names><![CDATA[A. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Bracey]]></surname>
<given-names><![CDATA[M. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Lichtman]]></surname>
<given-names><![CDATA[A. H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Proceedings of the National Academy of Sciences of the United States of America]]></source>
<year>2004</year>
<volume>101</volume>
<numero>29</numero>
<issue>29</issue>
<page-range>10821-6</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Endocannabinoid signalling in the blood of patients with schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Marchi]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[de Petrocellis]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[de Orlando]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Daniele]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Fezza]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[di Marzo]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<source><![CDATA[Lipids in Health and Disease]]></source>
<year>2003</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>5</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Determination and characterization of a cannabinoid receptor in rat brain]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Devane]]></surname>
<given-names><![CDATA[W. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Dysarz]]></surname>
<given-names><![CDATA[F. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[M. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Melvin]]></surname>
<given-names><![CDATA[L. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Howlett]]></surname>
<given-names><![CDATA[A. C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Molecular Pharmacology]]></source>
<year>1988</year>
<volume>34</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>605-13</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Isolation and structure of a brain constituent that binds to the cannabinoid receptor]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Devane]]></surname>
<given-names><![CDATA[W. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hanus]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Breuer]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pertwee]]></surname>
<given-names><![CDATA[R. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Stevenson]]></surname>
<given-names><![CDATA[L. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Griffin]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Mechoulam]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Science]]></source>
<year>1992</year>
<volume>258</volume>
<numero>5090</numero>
<issue>5090</issue>
<page-range>1946-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Egertová]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Giang]]></surname>
<given-names><![CDATA[D. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Cravatt]]></surname>
<given-names><![CDATA[B. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Elphick]]></surname>
<given-names><![CDATA[M. R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Proceedings. Biological Sciences/ The Royal Society]]></source>
<year>1998</year>
<volume>265</volume>
<numero>1410</numero>
<issue>1410</issue>
<page-range>2081-5</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eggan]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Hashimoto]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Lewis]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychiatry Research-Neuroimaging]]></source>
<year>2008</year>
<volume>65</volume>
<numero>7^s772</numero>
<issue>7^s772</issue>
<supplement>772</supplement>
<page-range>784</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cannabis use predicts future psychotic symptoms, and vice versa]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferdinand]]></surname>
<given-names><![CDATA[R. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Sondeijker]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[van der Ende]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Selten]]></surname>
<given-names><![CDATA[J. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Huizink]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Verhulst]]></surname>
<given-names><![CDATA[F. C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Addiction]]></source>
<year>2005</year>
<volume>100</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>612-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaoni]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Mechoulam]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Journal of the American Chemical Society]]></source>
<year>1971</year>
<volume>93</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>217-24</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[CB1 Cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gerdeman]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Lovinger]]></surname>
<given-names><![CDATA[D. M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Journal of Neurophysiology]]></source>
<year>2008</year>
<volume>85</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>468-71</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gessa]]></surname>
<given-names><![CDATA[G. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Casu]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Carta]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Mascia]]></surname>
<given-names><![CDATA[M. S.]]></given-names>
</name>
</person-group>
<source><![CDATA[European Journal of Pharmacology]]></source>
<year>1998</year>
<volume>355</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>119-24</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giuffrida]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Leweke]]></surname>
<given-names><![CDATA[F. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Gerth]]></surname>
<given-names><![CDATA[C. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Schreiber]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Koethe]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Faulhaber]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Piomelli]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuropsychopharmacology]]></source>
<year>2004</year>
<volume>29</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2108-14</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Dopamine activation of endogenous cannabinoid signaling in dorsal striatum]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giuffrida]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Parsons]]></surname>
<given-names><![CDATA[L. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Kerr]]></surname>
<given-names><![CDATA[T. M.]]></given-names>
</name>
<name>
<surname><![CDATA[de Fonseca]]></surname>
<given-names><![CDATA[F. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Navarro]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Piomelli]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature Neuroscience]]></source>
<year>1999</year>
<volume>2</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>26-30</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The effects of acute treatment with &#916;9-THC on exploratory behaviour and memory in the rat]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández-Tristán]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Arévalo]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Canals]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Leret]]></surname>
<given-names><![CDATA[M. L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Journal of Physiology and Biochemistry]]></source>
<year>2000</year>
<volume>56</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-24</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effects of delta-9 tetrahydrocannabinol on delayed match to sample performance in rats: alternations in short-term memory associated with changes in task specific firing of hippocampal cells]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heyser]]></surname>
<given-names><![CDATA[C. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Hampson]]></surname>
<given-names><![CDATA[R. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Deadwyler]]></surname>
<given-names><![CDATA[S. A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Journal of Pharmacology and Experimental Therapeutic]]></source>
<year>1993</year>
<volume>264</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>294-307</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cannabinoid physiology and pharmacology: 30 years of progress]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Howlett]]></surname>
<given-names><![CDATA[A. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Breivogel]]></surname>
<given-names><![CDATA[C. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Childers]]></surname>
<given-names><![CDATA[S. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Deadwyler]]></surname>
<given-names><![CDATA[S. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hampson]]></surname>
<given-names><![CDATA[R. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Porrino]]></surname>
<given-names><![CDATA[L. J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuropharmacology]]></source>
<year>2004</year>
<volume>47</volume>
<numero>^sSuppl. 1</numero>
<issue>^sSuppl. 1</issue>
<supplement>Suppl. 1</supplement>
<page-range>345-58</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Delta9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jentsch]]></surname>
<given-names><![CDATA[J. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Andrusiak]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Tran]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Bowers Jr.]]></surname>
<given-names><![CDATA[M. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Roth]]></surname>
<given-names><![CDATA[R. H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuropsychopharmacology]]></source>
<year>1997</year>
<volume>16</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>426-32</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Katona]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Rancz]]></surname>
<given-names><![CDATA[E. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Acsády]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Ledent]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Mackie]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Hajos]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Freund]]></surname>
<given-names><![CDATA[T. F.]]></given-names>
</name>
</person-group>
<source><![CDATA[The Journal of Neuroscience]]></source>
<year>2001</year>
<volume>21</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>9506-18</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Katona]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Sperlágh]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Maglóczky]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Sántha]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Köfalvi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Czirják]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Freund]]></surname>
<given-names><![CDATA[T. F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroscience]]></source>
<year>2000</year>
<volume>100</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>797-804</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Molecular composition of the endocannabinoid system at glutamatergic synapses]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Katona]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Urbán]]></surname>
<given-names><![CDATA[G. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Wallace]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ledent]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Piomelli]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Freund]]></surname>
<given-names><![CDATA[T. F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Journal of Neuroscience]]></source>
<year>2006</year>
<volume>26</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>5628-37</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cannabinoid receptors in the central nervous system: their signaling and roles in disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kendall]]></surname>
<given-names><![CDATA[D. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Yudowski]]></surname>
<given-names><![CDATA[G. A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Frontiers in Cellular Neuroscience]]></source>
<year>2017</year>
<volume>10</volume>
<page-range>294</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khaspekov]]></surname>
<given-names><![CDATA[L. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Verca]]></surname>
<given-names><![CDATA[M. S. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Frumkina]]></surname>
<given-names><![CDATA[L. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Hermann]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Marsicano]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Lutz]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<source><![CDATA[European Journal of Neuroscience]]></source>
<year>2004</year>
<volume>19</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1691-8</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Elevated endogenous cannabinoids in schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leweke]]></surname>
<given-names><![CDATA[F. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Giuffrida]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Wurster]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
<name>
<surname><![CDATA[Emrich]]></surname>
<given-names><![CDATA[H. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Piomelli]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroreport]]></source>
<year>1999</year>
<volume>10</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1665-9</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lichtman]]></surname>
<given-names><![CDATA[A. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Dimen]]></surname>
<given-names><![CDATA[K. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[B. R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychopharmacology]]></source>
<year>1995</year>
<volume>119</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>282-90</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Anandamide hydrolase: a guardian angel of human reproduction?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maccarrone]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Finazzi-Agro]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Trends in Pharmacological Sciences]]></source>
<year>2004</year>
<volume>25</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>353-7</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Advances in the physiology of GPR55 in the central nervous system]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marichal-Cancino]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Fajardo-Valdéz]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Contreras]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Méndez-Díaz]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Prospéro-García]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
</person-group>
<source><![CDATA[Current Neuropharmacology]]></source>
<year>2016</year>
<volume>14</volume>
<numero>999</numero>
<issue>999</issue>
<page-range>1</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The endogenous cannabinoid system controls extinction of aversive memories]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marsicano]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Wotjak]]></surname>
<given-names><![CDATA[C. T.]]></given-names>
</name>
<name>
<surname><![CDATA[Azad]]></surname>
<given-names><![CDATA[S. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Bisogno]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Rammes]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Cascio]]></surname>
<given-names><![CDATA[M. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Lutz]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature]]></source>
<year>2002</year>
<volume>418</volume>
<numero>6897</numero>
<issue>6897</issue>
<page-range>530-4</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[(AAT) n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Gras]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Hoenicka]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Ponce]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Jiménez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez-Arriero]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Hernandez]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Rubio]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[European Archives of Psychiatry and Clinical Neuroscience]]></source>
<year>2006</year>
<volume>256</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>437-41</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Structure of a cannabinoid receptor and functional expression of the cloned cDNA]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Matsuda]]></surname>
<given-names><![CDATA[L. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Lolait]]></surname>
<given-names><![CDATA[S. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Brownstein]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[A C.]]></given-names>
</name>
<name>
<surname><![CDATA[Bonner]]></surname>
<given-names><![CDATA[T. I.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature]]></source>
<year>1990</year>
<volume>346</volume>
<numero>6284</numero>
<issue>6284</issue>
<page-range>561-4</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Persistent cannabis users show neuropsychological decline from childhood to midlife]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meier]]></surname>
<given-names><![CDATA[M. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Caspi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ambler]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Harrington]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Houts]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Keefe]]></surname>
<given-names><![CDATA[R. S. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Moffitt]]></surname>
<given-names><![CDATA[T. E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Proceedings of the National Academy of Sciences]]></source>
<year>2012</year>
<volume>109</volume>
<numero>40</numero>
<issue>40</issue>
<page-range>E2657-64</page-range></nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muñoz-Arenas]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Paz-Bermúdez]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Báez-Cordero]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Caballero-Florán]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[González-Hernández]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Florán]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Limón]]></surname>
<given-names><![CDATA[I. D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Synapse]]></source>
<year>2015</year>
<volume>69</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>103-14</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Molecular characterization of peripheral receptor for cannabinoids]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Munro]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[K. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Abu-Shaar]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature]]></source>
<year>1993</year>
<volume>365</volume>
<numero>6441</numero>
<issue>6441</issue>
<page-range>61</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ohno-Shosaku]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Maejima]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Kano]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuron]]></source>
<year>2001</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>729-38</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palkovits]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Harvey-White]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Kovacs]]></surname>
<given-names><![CDATA[Z. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Bobest]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Lovas]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Kunos]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroscience]]></source>
<year>2008</year>
<volume>152</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1032-9</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pamplona]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Takahashi]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroscience Letters]]></source>
<year>2006</year>
<volume>397</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>88-92</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pamplona]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Prediger]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Pandolfo]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Takahashi]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychopharmacology]]></source>
<year>2006</year>
<volume>188</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>641-9</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Immunohistochemical localization of the neural cannabinoid receptor in rat brain]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pettit]]></surname>
<given-names><![CDATA[D. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Harrison]]></surname>
<given-names><![CDATA[M. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Olson]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Spencer]]></surname>
<given-names><![CDATA[R. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Cabral]]></surname>
<given-names><![CDATA[G. A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Journal of Neuroscience Research]]></source>
<year>1998</year>
<volume>51</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>391-402</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The molecular logic of endocannabinoid signalling]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piomelli]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature Reviews Neuroscience]]></source>
<year>2003</year>
<volume>4</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>873-84</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[D9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: An in vivo microdialysis study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pistis]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ferraro]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Pira]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Flore]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Tanganelli]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Luigi]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Devoto]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Brain Research]]></source>
<year>2002</year>
<volume>948</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>155-8</page-range></nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Impairment of endocannabinoids activity in the dorsolateral striatum delays extinction of behavior in a procedural memory task in rats]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rueda-Orozco]]></surname>
<given-names><![CDATA[P. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Montes-Rodriguez]]></surname>
<given-names><![CDATA[C. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Soria-Gomez]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Méndez-Díaz]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Prospéro-García]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuropharmacology]]></source>
<year>2008</year>
<volume>55</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>55-62</page-range></nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Working memory performance in young adults is associated to the AATn polymorphism of the CNR1 gene]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[A. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Carrillo]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Vadillo]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Carnevale]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Prospéro-García]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
</person-group>
<source><![CDATA[Behavioural Brain Research]]></source>
<year>2013</year>
<volume>236</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>62-6</page-range></nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Involvement of the AATn polymorphism of the CNR1 gene in the efficiency of procedural learning in humans]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz-Contreras]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado-Herrera]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[García-Vaca]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Almeida-Rosas]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Soria-Rodríguez]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Soriano-Bautista]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Prospéro-García]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroscience Letters]]></source>
<year>2011</year>
<volume>494</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>202-6</page-range></nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soria]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Matias]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Rueda]]></surname>
<given-names><![CDATA[P. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Cisneros]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Petrosino]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Navarro]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Prospéro]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
</person-group>
<source><![CDATA[British Journal of Pharmacology]]></source>
<year>2007</year>
<volume>151</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1109-16</page-range></nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Takahashi]]></surname>
<given-names><![CDATA[R. N.]]></given-names>
</name>
<name>
<surname><![CDATA[Pamplona]]></surname>
<given-names><![CDATA[F. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandes]]></surname>
<given-names><![CDATA[M. S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroscience Letters]]></source>
<year>2005</year>
<volume>380</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>270-5</page-range></nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsou]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Sañudo-Peña]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mackie]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroscience]]></source>
<year>1998</year>
<volume>83</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>393-411</page-range></nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ujike]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Takaki]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Nakata]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Tanaka]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Takeda]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Kodama]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Kuroda]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Molecular Psychiatry]]></source>
<year>2002</year>
<volume>7</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>515-8</page-range></nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[van Laere]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Koole]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Sanabria Bohorquez]]></surname>
<given-names><![CDATA[S. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Goffin]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Guenther]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Belanger]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Burns]]></surname>
<given-names><![CDATA[H. D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Journal of Nuclear Medicine]]></source>
<year>2008</year>
<volume>49</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>439-45</page-range></nlm-citation>
</ref>
<ref id="B59">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Varvel]]></surname>
<given-names><![CDATA[S. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Wise]]></surname>
<given-names><![CDATA[L. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Niyuhire]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Cravatt]]></surname>
<given-names><![CDATA[B. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Lichtman]]></surname>
<given-names><![CDATA[A. H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuropsychopharmacology]]></source>
<year>2007</year>
<volume>32</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1032-41</page-range></nlm-citation>
</ref>
<ref id="B60">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Endocannabinoid lipids and mediated system: implications for alcoholism and neuropsychiatric disorders]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vinod]]></surname>
<given-names><![CDATA[K. Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Hungund]]></surname>
<given-names><![CDATA[B. L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Life Sciences]]></source>
<year>200</year>
<volume>77</volume>
<numero>14</numero>
<issue>14</issue>
<page-range>1569-83</page-range></nlm-citation>
</ref>
<ref id="B61">
<nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[The health and social effects of nonmedical cannabis use]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B62">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Brain cannabinoid CB(2) receptors modulate cocaine&#8217;s actions in mice]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xi]]></surname>
<given-names><![CDATA[Z.-X.]]></given-names>
</name>
<name>
<surname><![CDATA[Peng]]></surname>
<given-names><![CDATA[X.-Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Q.-R.]]></given-names>
</name>
<name>
<surname><![CDATA[Gardner]]></surname>
<given-names><![CDATA[E. L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature Neuroscience]]></source>
<year>2011</year>
<volume>14</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1160-6</page-range></nlm-citation>
</ref>
<ref id="B63">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[BDNF-induced endocannabinoid release modulates neocortical glutamatergic neurotransmission]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yeh]]></surname>
<given-names><![CDATA[M. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Selvam]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Levine]]></surname>
<given-names><![CDATA[E. S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Synapse]]></source>
<year>2017</year>
<volume>71</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>e21962</page-range></nlm-citation>
</ref>
<ref id="B64">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Selective antagonist [3H]SR141716A binding to cannabinoid cb1 receptors is increased in the anterior cingulate cortex in schizophrenia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zavitsanou]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Garrick]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[X. F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Progress in Neuro-Psychopharmacology and Biological Psychiatry]]></source>
<year>2004</year>
<volume>28</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>355-60</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
